Abstract

Lumican is an extracellular matrix protein modified as a proteoglycan in some tissues. The core protein with leucine-rich repeats, characteristic of the leucine-rich-repeat superfamily, binds collagen fibrils and regulates its structure. In addition, we believe that lumican sequestered in the pericellular matrix interacts with cell surface proteins for specific cellular functions. Here we show that bacterial lipopolysaccharide sensing by the Toll-like receptor 4 signaling pathway and innate immune response is regulated by lumican. Primary cultures of lumican-deficient (Lum(-/-)) macrophages show impaired innate immune response to lipopolysaccharides with lower induction of tumor necrosis factor alpha (TNFalpha) and interleukin-6. Macrophage response to other pathogen-associated molecular patterns is not adversely affected by lumican deficiency, suggesting a specific role for the lumican core protein in the Toll-like receptor 4 pathway. An exogenous recombinant lumican core protein increases lipopolysaccharide-mediated TNFalpha induction and partially rescues innate immune response in Lum(-/-) macrophages. We further show that the core protein binds lipopolysaccharide. Immunoprecipitation of lumican from peritoneal lavage co-precipitates CD14, a cell surface lipopolysaccharide-binding protein that is involved in its presentation to Toll-like receptor 4. The Lum(-/-) mice are hypo-responsive to lipopolysaccharide-induced septic shock, with poor induction of pro-inflammatory cytokines, TNFalpha, and interleukins 1beta and 6 in the serum. Taken together, the data indicates a novel role for lumican in the presentation of bacterial lipopolysaccharide to CD14 and host response to this bacterial endotoxin.

Highlights

  • Innate immune response involves recognition of pathogenassociated molecular patterns (PAMPs) by pathogen recognition Toll-like receptors (TLR) present on the surface of antigenpresenting macrophages and dendritic cells [4, 5]

  • LumϪ/Ϫ Mice Are Hypo-responsive to Bacterial LPS—To investigate the effects of lumican deficiency on innate immune functions, we tested the response of LumϪ/Ϫ mice to LPS-induced septic shock

  • A log rank test indicated that the survival trend between LumϪ/Ϫ and Lumϩ/ϩ mice treated with E. coli or S. typhimurium LPS was significantly different (p ϭ 0.039)

Read more

Summary

EXPERIMENTAL PROCEDURES

Ultra pure Escherichia coli (0111:B4) LPS was purchased from List Biological Laboratories, Inc., Salmonella typhimurium LPS, Staphylococcus aureus peptidoglycan (PGN), N-acetylmuramyl-L-alanyl-D-isoglutamine hydrate (MDP), and polyinosinic-polycytidylic acid sodium salt (poly I:C) were purchased from Sigma. Cell Lines—HEK-293 cells (Invitrogen), 293-rLum (stable transfectants expressing recombinant lumican, rLum), and HEK-293 expressing TLR4, MD2, and CD14 (293-hTLR4/ MD2-CD14, InviroGen) were cultured in Dulbecco’s modified Eagle’s medium with 10% fetal calf serum and 1% of 100ϫ antibiotic antimycotic (Sigma). Selected cytokines were measured by standard sandwich enzyme linked-immunosorbent assay (ELISA) in the serum or cell culture medium. Macrophage extracts of rLum-treated and appropriate control cells were added to wells precoated with a goat polyclonal anti-lumican antibody (Santa Cruz Biotechnologies) and washed, and the presence of rLum was detected using a rabbit polyclonal against rLum [29]. Elicited primary macrophages were harvested from the peritoneal lavage of wild type mice, and total protein was extracted using the M-PER extraction kit (Pierce). The immunoprecipitate was resolved by SDS-PAGE, and CD14 was detected by immunoblotting (BAF982, R&D Systems)

Statistical Methods
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call